Sfoglia per Autore
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation.
2012-01-01 Serio, B; Rosamilio, R; Giudice, V; Pepe, Stefano; Zeppa, Pio; Esposito, Silvano; Pezzullo, L; Rocco, M; Montuori, N; Selleri, Carmine
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation
2012-01-01 Bianca, Serio; Rosa, Rosamilio; Giudice, Valentina; Pepe, Stefano; Zeppa, Pio; Esposito, Silvano; Luca, Pezzullo; Monia, Rocco; Nunzia, Montuori; Selleri, Carmine
Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report
2012-01-01 Bianca, Serio; Rosa, Rosamilio; Giudice, Valentina; Zeppa, Pio; Esposito, Silvano; Raffaele, Fontana; Silvana, Annunziata; Ida Lucia Ferrara, ; Selleri, Carmine
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients
2013-01-01 Pezzullo, L; Serio, B; Fontana, R; Ferrara, I; Sessa, M; Giudice, V; Villani, G; Rocco, M; Selleri, Carmine
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation
2013-01-01 Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Ferrara, I; Rocco, M; Giudice, V; Sessa, M; De Luca, C; Selleri, Carmine
Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia
2013-01-01 Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Giudice, V; Sessa, M; Ferrara, I; De Luca, C; Rocco, M; Selleri, Carmine
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation
2013-01-01 Pezzullo, L; Fontana, R; Serio, B; Annunziata, S; Sessa, M; Rosamilio, R; Ferrara, I; Giudice, V; Villani, G; Rocco, M; Selleri, Carmine
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations
2013-01-01 Rocco, M; Carrizzo, A; Annunziata, S; Sessa, M; Giudice, V; Rosamilio, R; Serio, B; Trimarco, V; Damato, A; Vecchione, C; Selleri, Carmine
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation
2013-01-01 Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Ferrara, I; Rocco, M; Giudice, V; De Rosa, G; Ricci, P; Montuori, N; Selleri, Carmine
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide
2013-01-01 Fontana, R; Baldi, C; Sabattini, E; Napolitano, C; Pezzullo, L; Giudice, V; Valvano, L; Selleri, Carmine
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients
2013-01-01 Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Ferrara, I; Rocco, M; Giudice, V; Sessa, M; Montuori, N; Selleri, Carmine
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy
2013-01-01 Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Rocco, M; Villani, G; Giudice, V; Sessa, M; Russo, R; Baldi, C; Ferrara, I; Selleri, Carmine
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients
2013-01-01 Rocco, M; Villani, G; Sessa, M; Rosamilio, R; Giudice, V; Pezzullo, L; Fontana, R; Serio, B; Annunziata, S; Ferrara, I; Selleri, Carmine
OPSI threat in hematological patients
2013-01-01 Serio, B; Pezzullo, L; Giudice, V; Fontana, R; Annunziata, S; Ferrara, I; Rosamilio, R; De Luca, C; Rocco, M; Montuori, N; Selleri, C
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation
2014-01-01 Selleri, Carmine; Giudice, V.; Serio, B.; Sessa, M.; Pezzullo, L.; Fontana, R.; Annunziata, S.; Ferrara, I.; Rocco, M.
Endocrine disorders after autologous and allogeneic stem cell transplantation
2014-01-01 Serio, B.; Giudice, V.; Sessa, M.; Pezzullo, L.; Ferrara, I.; Rocco, M.; Fontana, R.; Annunziata, S.; Selleri, Carmine
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients
2014-01-01 Sessa, M; Giudice, V; Esposito, B; Pezzullo, L; Serio, B; Ferrara, I; Selleri, Carmine
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders
2014-01-01 Sessa, M; Giudice, V; Serio, B; Pezzullo, L; Selleri, Carmine
Flow Cytometric Detection Of B-cell Membrane Markers CD5, CD11c, CD20, CD38 And CD49d May Predict Outcome In Chronic Lymphocytic Leukemia And Non-Hodgkin Lymphoma
2014-01-01 Giudice, V; Rocco, M; Villani, G; Sessa, M; Selleri, Carmine
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing
2014-01-01 Montuori, N.; Selleri, Carmine; Serio, B.; Giudice, V.; Sessa, M.; Gorrasi, A.; Li Santi, A.; Rocco, M.; Ricci, P.; Ragno, Pia
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. | 1-gen-2012 | Serio, B; Rosamilio, R; Giudice, V; Pepe, Stefano; Zeppa, Pio; Esposito, Silvano; Pezzullo, L; Rocco, M; Montuori, N; Selleri, Carmine | |
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation | 1-gen-2012 | Bianca, Serio; Rosa, Rosamilio; Giudice, Valentina; Pepe, Stefano; Zeppa, Pio; Esposito, Silvano; Luca, Pezzullo; Monia, Rocco; Nunzia, Montuori; Selleri, Carmine | |
Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report | 1-gen-2012 | Bianca, Serio; Rosa, Rosamilio; Giudice, Valentina; Zeppa, Pio; Esposito, Silvano; Raffaele, Fontana; Silvana, Annunziata; Ida Lucia Ferrara, ; Selleri, Carmine | |
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients | 1-gen-2013 | Pezzullo, L; Serio, B; Fontana, R; Ferrara, I; Sessa, M; Giudice, V; Villani, G; Rocco, M; Selleri, Carmine | |
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation | 1-gen-2013 | Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Ferrara, I; Rocco, M; Giudice, V; Sessa, M; De Luca, C; Selleri, Carmine | |
Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia | 1-gen-2013 | Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Giudice, V; Sessa, M; Ferrara, I; De Luca, C; Rocco, M; Selleri, Carmine | |
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation | 1-gen-2013 | Pezzullo, L; Fontana, R; Serio, B; Annunziata, S; Sessa, M; Rosamilio, R; Ferrara, I; Giudice, V; Villani, G; Rocco, M; Selleri, Carmine | |
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations | 1-gen-2013 | Rocco, M; Carrizzo, A; Annunziata, S; Sessa, M; Giudice, V; Rosamilio, R; Serio, B; Trimarco, V; Damato, A; Vecchione, C; Selleri, Carmine | |
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation | 1-gen-2013 | Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Ferrara, I; Rocco, M; Giudice, V; De Rosa, G; Ricci, P; Montuori, N; Selleri, Carmine | |
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide | 1-gen-2013 | Fontana, R; Baldi, C; Sabattini, E; Napolitano, C; Pezzullo, L; Giudice, V; Valvano, L; Selleri, Carmine | |
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients | 1-gen-2013 | Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Ferrara, I; Rocco, M; Giudice, V; Sessa, M; Montuori, N; Selleri, Carmine | |
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy | 1-gen-2013 | Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Rocco, M; Villani, G; Giudice, V; Sessa, M; Russo, R; Baldi, C; Ferrara, I; Selleri, Carmine | |
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients | 1-gen-2013 | Rocco, M; Villani, G; Sessa, M; Rosamilio, R; Giudice, V; Pezzullo, L; Fontana, R; Serio, B; Annunziata, S; Ferrara, I; Selleri, Carmine | |
OPSI threat in hematological patients | 1-gen-2013 | Serio, B; Pezzullo, L; Giudice, V; Fontana, R; Annunziata, S; Ferrara, I; Rosamilio, R; De Luca, C; Rocco, M; Montuori, N; Selleri, C | |
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation | 1-gen-2014 | Selleri, Carmine; Giudice, V.; Serio, B.; Sessa, M.; Pezzullo, L.; Fontana, R.; Annunziata, S.; Ferrara, I.; Rocco, M. | |
Endocrine disorders after autologous and allogeneic stem cell transplantation | 1-gen-2014 | Serio, B.; Giudice, V.; Sessa, M.; Pezzullo, L.; Ferrara, I.; Rocco, M.; Fontana, R.; Annunziata, S.; Selleri, Carmine | |
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients | 1-gen-2014 | Sessa, M; Giudice, V; Esposito, B; Pezzullo, L; Serio, B; Ferrara, I; Selleri, Carmine | |
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders | 1-gen-2014 | Sessa, M; Giudice, V; Serio, B; Pezzullo, L; Selleri, Carmine | |
Flow Cytometric Detection Of B-cell Membrane Markers CD5, CD11c, CD20, CD38 And CD49d May Predict Outcome In Chronic Lymphocytic Leukemia And Non-Hodgkin Lymphoma | 1-gen-2014 | Giudice, V; Rocco, M; Villani, G; Sessa, M; Selleri, Carmine | |
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing | 1-gen-2014 | Montuori, N.; Selleri, Carmine; Serio, B.; Giudice, V.; Sessa, M.; Gorrasi, A.; Li Santi, A.; Rocco, M.; Ricci, P.; Ragno, Pia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile